Addiction, Abuse, and Misuse
DURAGESIC exposes patients and different users to the risks of opioid addiction, abuse, and misuse, which may cause o.d. and death. Assess every patient’s conditions before prescribing DURAGESIC, and monitor all patients frequently for the development of those behaviors or conditions.
Life-threatening respiratory Depression
Serious, dangerous, or fatal respiratory depression could occur with use of DURAGESIC, even once used as suggested. Check for respiratory depression, especially during initiation of DURAGESIC or following a dose increase. as a result of the chance of respiratory depression, DURAGESIC is contraindicated to be used as an as-needed analgesic, in non-opioid tolerant patients, in acute pain, and in surgical pain.
Deaths because of a fatal overdose of painkiller have occurred once kids and adults were accidentally exposed to DURAGESIC. Strict adherence to the suggested handling and disposal directions is of the utmost importance to stop accidental exposure.
Neonatal Opioid Withdrawal Syndrome
Prolonged use of DURAGESIC throughout maternity may result in baby opioid withdrawal syndrome, which can be severe if not recognized and treated, and needs management consistent with protocols developed by pediatrics specialists. If opioid use is needed for a prolonged amount in an exceedingly pregnant lady, advise the patient the chance of infant opioid withdrawal syndrome and make sure that appropriate treatment are available.
Cytochrome P450 3A4 Interaction
Additionally, discontinuance of a concomitantly used cytochrome P450 3A4 inducer could lead to a rise in fentanyl plasma concentration. Monitor patients receiving DURAGESIC and any CYP3A4 substance or inducer.
Exposure To Heat
Exposure of the DURAGESIC application website and surrounding space to direct external heat credits, like heating pads or electrical blankets, heat or tanning lamps, sunbathing, hot baths, saunas, hot tubs, and heated water beds could increase fentanyl absorption and has resulted in fatal o.d. of painkiller and death. Patients carrying DURAGESIC systems WHO develop fever or inflated core blood heat because of strenuous effort also are in danger for inflated painkiller exposure and will need an adjustment within the dose of DURAGESIC to avoid drug and death.